| abstract |
The present invention relates to a pharmaceutical composition for treating spinal cord injury containing ghrelin as an active ingredient, specifically, the effect of improving the motor function after spinal nerve injury, the effect of inhibiting spinal nerve cell death, the effect of inhibiting spinal cord oligodendrocyte death, and wound space Provided is a method for treating central nervous system disease in a patient, comprising administering to the patient suffering from central nervous system disease a pharmaceutical composition for treating spinal cord injury comprising ghrelin exhibiting a reducing effect, an axon depressing effect, and a demyelination reducing effect. It is. The composition comprising ghrelin of the present invention as an active ingredient can be used as a therapeutic agent for central nervous system diseases showing spinal cord injury, death of neurons and oligodendrocytes, axon degeneration and demyelination. |